Scientists test Next-Generation anthrax shot
NCT ID NCT05997264
Summary
This study is testing the safety and immune response of an investigational anthrax vaccine called AV7909. About 220 healthy adults will receive either a full dose, half dose, or placebo shot in a series over one year, including booster doses. Researchers will closely monitor for side effects and measure how well the body produces protective antibodies against anthrax.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTHRAX are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Accellacare Knoxville
Jefferson City, Tennessee, 37760, United States
-
Accellacare Knoxville
Knoxville, Tennessee, 37912, United States
-
Accellacare Knoxville
Knoxville, Tennessee, 37938, United States
-
Accellacare of Hickory
Hickory, North Carolina, 28601, United States
-
Accellacare of Piedmont
Statesville, North Carolina, 28625, United States
-
Accellacare of Salisbury
Salisbury, North Carolina, 28144, United States
-
Accellacare of Winston-Salem
Winston-Salem, North Carolina, 27103, United States
Conditions
Explore the condition pages connected to this study.